THE EFFICACY OF SITAGLIPTIN ON INSULIN TREATMENT FOR JAPANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Matsuhashi, Y. [1 ]
Chikazawa, S. [1 ]
Matsui, J. [1 ]
Daimon, M. [1 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70480-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO186
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [1] Efficacy of Concomitant Therapy in Japanese Type 2 Diabetes Mellitus Patients With Insulin and Sitagliptin, a DPP-4 Inhibitor
    Nakagami, Tomoko
    Ide, Risa
    Iwasaki, Naoko
    Ogata, Makiko
    Oya, Junko
    Osawa, Mari
    Tanaka, Nobue
    Takaike, Hiroko
    Sato, Asako
    Miura, Junnosuke
    Uchigata, Yasuko
    DIABETES, 2013, 62 : A298 - A298
  • [2] Efficacy and Safety of Switching from Basal Insulin to Sitagliptin in Japanese Type 2 Diabetes Patients
    Harashima, S. -I.
    Tanaka, D.
    Yamane, S.
    Ogura, M.
    Fujita, Y.
    Murata, Y.
    Seike, M.
    Koizumi, T.
    Aono, M.
    Wang, Y.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (03) : 231 - 238
  • [3] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [4] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [5] Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
    Sato, Seiji
    Saisho, Yoshifumi
    Kou, Kinsei
    Meguro, Shu
    Tanaka, Masami
    Irie, Junichiro
    Kawai, Toshihide
    Itoh, Hiroshi
    PLOS ONE, 2015, 10 (03):
  • [6] Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy
    Kadowaki T.
    Tajima N.
    Odawara M.
    Minamide T.
    Kawashima M.
    Yanagida D.
    Okamoto T.
    Arjona Ferreira J.C.
    Diabetology International, 2013, 4 (3) : 160 - 172
  • [7] Comparison of Efficacy and Safety of Sitagliptin and Glimepiride in Treatment of Type 2 Diabetes Mellitus
    Hussain, Shabir
    Mustafa, Amjad
    Mumtaz, Arif
    Shaheen, Ghazala
    Qaiser, Fawad
    Soban, Mohammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2800 - 2803
  • [8] Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Katakami, Naoto
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 633 - 639
  • [9] Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus
    Kawamori, R.
    Kadowaki, T.
    Ishii, H.
    Iwasaki, M.
    Iwamoto, Y.
    DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 891 - 899
  • [10] Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
    Yu, Miao
    Shankar, R. Ravi
    Zhang, Ruya
    Zhang, Ye
    Lin, Jianxin
    O'Neill, Edward A.
    Chen, Guojuan
    Liu, Shu
    Tu, Yingmei
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 408 - 411
12345